## Clinical Context This child presents with **fasting hypoglycemia** (low glucose with inappropriately low insulin) and **elevated lactate**, which together point to a defect in hepatic glucose production—most likely a glycolytic or gluconeogenic enzyme deficiency, classically **glycogen storage disease type I (GSD-I, glucose-6-phosphatase deficiency)**. ## Immediate Management Priority **Key Point:** In acute symptomatic hypoglycemia with seizures, the immediate priority is to **raise blood glucose to prevent neurological injury**, not to confirm diagnosis. **High-Yield:** The constellation of: - Severe fasting hypoglycemia (glucose <40 mg/dL) - Elevated lactate (indicating blocked gluconeogenesis) - Hepatomegaly (glycogen accumulation) - Inappropriately suppressed insulin (rules out insulinoma) ...is pathognomonic for **hepatic glucose production defects** (GSD-I, GSD-III, or fructose-1,6-bisphosphatase deficiency). ## Why Option 1 (IV Dextrose + Frequent Feeding) Is Correct 1. **Immediate stabilization:** IV dextrose 0.5 g/kg (or 0.25 g/kg if <25 kg) stops the seizure and prevents cerebral edema. 2. **Maintenance therapy:** Frequent meals (every 2–3 hours) with **cornstarch** (provides slow glucose release) or **uncooked cornstarch** (releases glucose over 4–6 hours) prevents recurrent hypoglycemia. 3. **Avoids diagnostic delay:** Diagnostic tests (fasting test, liver biopsy) are deferred until the child is stable and can be done electively. **Clinical Pearl:** In GSD-I, frequent feeding with cornstarch is the cornerstone of long-term management; it allows the child to maintain euglycemia without requiring continuous glucose infusions. ## Why Each Distractor Is Wrong | Option | Reason | |--------|--------| | **Formal 8-hour fasting test** | While diagnostic, this test is contraindicated in an acutely symptomatic, seizing child. It would worsen hypoglycemia and risk permanent neurological damage. Diagnosis can be confirmed once the child is stable. | | **Liver biopsy** | Invasive, requires general anesthesia, and carries bleeding risk in a child with likely hepatic synthetic dysfunction. Enzyme assay (glucose-6-phosphatase) or genetic testing is the gold standard, not histology. | | **Hepatic glucose output measurement + genetic testing** | Isotope dilution is a research tool, not a bedside management step. Genetic testing is confirmatory but not urgent; it does not change acute management. | ## Treatment Algorithm ```mermaid flowchart TD A[Symptomatic Hypoglycemia + Seizures]:::urgent --> B[IV Dextrose 0.5 g/kg]:::action B --> C[Stabilize & Prevent Recurrence]:::action C --> D[Frequent Meals + Cornstarch]:::action D --> E{Stable?}:::decision E -->|Yes| F[Enzyme Assay / Genetic Testing]:::outcome E -->|No| G[Consider Continuous NG Feeding]:::action F --> H[Confirm GSD-I or Other Defect]:::outcome ``` **Mnemonic:** **FAST** for management of GSD hypoglycemia: - **F**requent feeding (every 2–3 hours) - **A**void fasting (>4 hours) - **S**tarch (cornstarch, uncooked) - **T**reat acutely with IV dextrose if symptomatic [cite:Harrison 21e Ch 356; Robbins 10e Ch 7]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.